Erez Asset Management, holding 5.5% of UMH Properties, alleges the company has spent 20 years issuing new shares to fund dividends that exceed available funds, diluting shareholders and destroying value. This practice is criticized as unnecessary under REIT rules and has contributed to UMH's poor shareholder returns despite asset growth. Erez is pushing for board changes and encourages shareholders to support reforms at UMH. They plan to file a proxy statement for the 2027 annual meeting to seek these changes.
UMH Properties is the subject of this report. For readers following real estate stocks, here is Pluang's market snapshot as of Nov 12, 2026 20:21 WIB: Among 47 priced US real estate stocks, 21 rose and 24 fell. Alexandria Real Estate Equities Inc (ARE) closed at USD 44.75 with a -0.73% change and 100% buy order activity. American Healthcare REIT Inc (AHR) traded at USD 58.80, down 0.73%, with a typical hold time of 17 days. American Tower Corp (AMT) rose 0.71% to USD 191.59, also with 100% buy order activity and a typical hold time of 86 days.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
